Dr. Floege presenting on IgA from his car in a snowstorm!
So amazed, our @glomcon.org fellows are very grateful, can't thank him enough π
Dr. Floege presenting on IgA from his car in a snowstorm!
So amazed, our @glomcon.org fellows are very grateful, can't thank him enough π
MGHkidneys not here yet but delighted to welcome our next class of fellows!
A familiar last name on the listβ¦
ODS has other risk factors that may be more important than correction.
Calling ODS a purely iatrogenic disease is preposterous in many cases. Blameful on docs, rates canβt always be controlled exactly. Litigation :(
Flaws of studies that guidelines are based on >> flaws of recent studies.
This data will be criticized like recent studies. But:
Not all slow correction is because of underlying disease. Hesitancy in correction/relowering are issues = increased LOS.
ODS: ill-defined, extremely rare, questionable relationship to rates (in an era where no one corrects >15)